| Literature DB >> 34914384 |
Gillian Laidlaw1, Vilius Franckevičius1.
Abstract
A palladium-catalyzed decarboxylative asymmetric allylic alkylation of thietane 1,1-dioxides via linear enolate intermediates from racemic starting materials has been developed. This process installs an α-sulfonyl tetrasubstituted stereogenic center with high enantioselectivity. The potential to transform the alkylated products to novel types of enantioenriched spirocycles for medicinal chemistry applications has also been demonstrated.Entities:
Year: 2021 PMID: 34914384 PMCID: PMC8762707 DOI: 10.1021/acs.orglett.1c04075
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005
Scheme 1Introduction
Scheme 2Three-Step Synthesis of Ketone and Ester Precursors
Reagents and conditions: (a) KMnO4 (2 equiv), CH2Cl2/H2O, rt, 94%; (b) LiHMDS (2.1 equiv), allyl chloroformate, THF, – 78 °C, 68%; (c) NaHMDS (1.1 equiv), R1COCl, THF, 0 °C; (d) KHMDS (1.1 equiv), R2OCOCl, THF, 0 °C. Abbreviations: THF, tetrahydrofuran; HMDS, bis(trimethylsilyl)amide.
Reaction Optimization Studiesa
| entry | ligand | solvent | yield (%) | ee (%) |
|---|---|---|---|---|
| 1 | 1,4-dioxane | 38 | 8 | |
| 2 | 1,4-dioxane | 80 | 34 | |
| 3 | 1,4-dioxane | 80 | 24 | |
| 4 | 1,4-dioxane | 78 | 83 | |
| 5 | 1,4-dioxane (0.1 M) | 84 | 79 | |
| 6 | 1,4-dioxane (0.2 M) | 80 | 75 | |
| 7 | MeCN | 71 | 1 | |
| 8 | PhMe | 78 | 22 | |
| 9 | Et2O | 71 | 38 | |
| 10 | THF | 70 | 41 | |
| 11 | CH2Cl2 | 98 | 65 | |
| 12 | 1,4-dioxane/CH2Cl2 (3/1) | 82 | 81 |
Conditions: 16a (0.17 mmol), [Pd2(dba)3] (2.5 mol %), (L1–4) (6.5 mol %). Abbreviation: dba, dibenzylideneacetone.
Isolated yield.
Enantiomeric excess determined by chiral HPLC;
Performed at 0 °C.
Scheme 3Pd-DAAA of Thietane 1,1-Dioxides
Isolated yields are given.
Enantiomeric excess determined by chiral HPLC.
Conditions: [Pd2(dba)3] (5 mol %), (S,S)-L4 (13 mol %).
Scheme 4Effect of Enolate Geometry
Conditions: [Pd2(dba)3] (2.5 mol %), (S,S)-L4 (6.5 mol %), 1,4-dioxane (0.04 M), rt, 18 h.
Scheme 5Mechanistic Study
Scheme 6Reaction Mechanism
Scheme 7Synthesis and Functionalization of Spirocycle 12
Conditions: (a) 9-BBN, NaOH, H2O2, THF, 62%; (b) Dess–Martin periodinane, CH2Cl2, 78%; (c) NH2Bhz, AcOH, NaBH(OAc)3, DCE, 57%; (d) TFA, CH2Cl2, quantitative; (e) EDCI·HCl, pyridine, DMAP, CH2Cl2, 89%; (f) BH3·THF, THF, 96%; (g) Pd(OH)2/C, H2, EtOH, TFA, 81%; (h) 4 N HCl, 1,4-dioxane, 95%. Functionalizations: (i) 12 (0.15 mmol), 4-bromobenzylaldehyde, AcOH, NaBH(OAc)3, DCE, 53%; (j) 12 (0.07 mmol), 4-bromobenzoyl chloride, Et3N, CH2Cl2, 84%; (k) 12 (0.15 mmol), 4-bromoacetophenone, Pd(OAc)2, rac-BINAP, Cs2CO3, toluene, 61%. Abbreviations: 9-BBN, 9-borabicyclo[3.3.1]nonane; Bhz, benzhydryl; DCE, 1,2-dichloroethane; TFA, trifluoroacetic acid; EDCI, N-(3-(dimethylamino)propyl)-N′-ethylcarbodiimide; DMAP, 4-(dimethylamino)pyridine; BINAP, 2,2′-bis(diphenylphosphino)-1,1′-binaphthalene. ‡For the purposes of ee determination by chiral HPLC analysis, 12 was first Boc-protected (see the Supporting Information, 28d).